PVMCV
Polaris Venture Management Co V Portfolio holdings
AUM
$14.1M
This Quarter Return
+13.87%
1 Year Return
+121.41%
3 Year Return
+278.88%
5 Year Return
+1,121.38%
10 Year Return
–
AUM
$128M
AUM Growth
+$128M
(+16%)
Cap. Flow
-$20.8M
Cap. Flow
% of AUM
-16.16%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
11
New
1
Increased
1
Reduced
1
Closed
1
Top Buys
| 1 |
Lyra Therapeutics
LYRA
|
$12.5M |
| 2 |
ATYR
aTyr Pharma
ATYR
|
$4 |
Top Sells
| 1 |
KALA BIO
KALA
|
$4.97M |
Sector Composition
| 1 | Healthcare | 51.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Fate Therapeutics
FATE
$120M
| $39.1M | 30.44% | 1,139,783 | – | – |
|
|
2
Lyra Therapeutics
LYRA
$11.5M
| $12.5M | 9.72% | +1,100,852 | New | +$12.5M |
|
3
Cartesian Therapeutics
RNAC
$261M
| $7.88M | 6.13% | 2,773,479 | – | – |
|
4
X4 Pharmaceuticals
XFOR
$84.2M
| $2.9M | 2.26% | 311,492 | – | – |
|
5
Neuronetics
STIM
$220M
| $1.41M | 1.1% | 732,583 | – | – |
|
6
Pulmatrix
PULM
$18M
| $618K | 0.48% | 359,439 | – | – |
|
|
ATYR
7
aTyr Pharma
ATYR
$527M
| $580K | 0.45% | 130,572 +1 | +0% | +$4 |
|
|
GNCA
8
DELISTED
Genocea Biosciences, Inc.
GNCA
| $566K | 0.44% | 246,078 | – | – |
|
9
Dare Bioscience
DARE
$27.2M
| $323K | 0.25% | 326,243 | – | – |
|
|
10
KALA BIO
KALA
$78.8M
| – | – | -565,289 | Closed | -$4.97M |
|